Rhumbline Advisers »

Cg Oncology shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Cg Oncology shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 30k 43.90

More positions owned by Rhumbline Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Berkshire Hathaway (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Visa (V)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Rhumbline Advisers

Top funds holding Cg Oncology

BlackRock
Vanguard Group
BVF
Henderson Group
Avidity Partners Management
RA Capital Management
Perceptive Advisors
Braidwell
T. Rowe Price Associates
Franklin Resources
Cormorant Asset Management
Frazier Life Sciences Management
Holocene Advisors
T. Rowe Price Investment Management
Foresite Capital Management V

View all funds holding Cg Oncology